Nuvo Research Inc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Morag who wrote (13991)	8/27/2005 12:55:27 PM
From: Cal Gary	Read Replies (1) of 14101

Judging from last week's trading, Mr D. M. (Market) X. wasn't too thrilled by the NR. Anyways, with some caveats, I am happy to see the return of WF10. I remind myself that I am invested in a Drug research company, so having a drug pipeline is important. Aside, I would have been happier to hear progress on Penecure. I suppose DMX still have the same WF10 research and reg group. From my point of view, the WF10 HIV Phase III was a major flug-up. I just hope they'll be more diligent with this next set of clinicals. I also hope management can outline more of the Euro studies, timelines, exactly what are the end points and costs. And before I leave, check out a Jim Kayne post from Jan 13, 2005. Message 20944888 Eerily. See points B and C. Have a great weekend.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next